Your browser doesn't support javascript.
loading
Mitogen-activated protein kinase activity drives cell trajectories in colorectal cancer.
Uhlitz, Florian; Bischoff, Philip; Peidli, Stefan; Sieber, Anja; Trinks, Alexandra; Lüthen, Mareen; Obermayer, Benedikt; Blanc, Eric; Ruchiy, Yana; Sell, Thomas; Mamlouk, Soulafa; Arsie, Roberto; Wei, Tzu-Ting; Klotz-Noack, Kathleen; Schwarz, Roland F; Sawitzki, Birgit; Kamphues, Carsten; Beule, Dieter; Landthaler, Markus; Sers, Christine; Horst, David; Blüthgen, Nils; Morkel, Markus.
Afiliación
  • Uhlitz F; Institute of Pathology, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
  • Bischoff P; IRI Life Sciences, Humboldt University of Berlin, Berlin, Germany.
  • Peidli S; German Cancer Consortium (DKTK) Partner Site Berlin, German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Sieber A; Institute of Pathology, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
  • Trinks A; Institute of Pathology, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
  • Lüthen M; IRI Life Sciences, Humboldt University of Berlin, Berlin, Germany.
  • Obermayer B; Institute of Pathology, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
  • Blanc E; IRI Life Sciences, Humboldt University of Berlin, Berlin, Germany.
  • Ruchiy Y; Institute of Pathology, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
  • Sell T; BIH Bioportal Single Cells, Berlin Institute of Health at Charité - Universitätsmedizin Berlin, Berlin, Germany.
  • Mamlouk S; Institute of Pathology, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
  • Arsie R; German Cancer Consortium (DKTK) Partner Site Berlin, German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Wei TT; Core Unit Bioinformatics (CUBI), Berlin Institute of Health at Charité Universitätsmedizin - Berlin, Berlin, Germany.
  • Klotz-Noack K; Core Unit Bioinformatics (CUBI), Berlin Institute of Health at Charité Universitätsmedizin - Berlin, Berlin, Germany.
  • Schwarz RF; Institute of Pathology, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
  • Sawitzki B; Institute of Pathology, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
  • Kamphues C; IRI Life Sciences, Humboldt University of Berlin, Berlin, Germany.
  • Beule D; Institute of Pathology, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
  • Landthaler M; German Cancer Consortium (DKTK) Partner Site Berlin, German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Sers C; Max Delbrück Center for Molecular Medicine, Berlin Institute for Medical Systems Biology (BIMSB), Berlin, Germany.
  • Horst D; Institute of Pathology, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
  • Blüthgen N; Max Delbrück Center for Molecular Medicine, Berlin Institute for Medical Systems Biology (BIMSB), Berlin, Germany.
  • Morkel M; Institute of Pathology, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
EMBO Mol Med ; 13(10): e14123, 2021 10 07.
Article en En | MEDLINE | ID: mdl-34409732
ABSTRACT
In colorectal cancer, oncogenic mutations transform a hierarchically organized and homeostatic epithelium into invasive cancer tissue lacking visible organization. We sought to define transcriptional states of colorectal cancer cells and signals controlling their development by performing single-cell transcriptome analysis of tumors and matched non-cancerous tissues of twelve colorectal cancer patients. We defined patient-overarching colorectal cancer cell clusters characterized by differential activities of oncogenic signaling pathways such as mitogen-activated protein kinase and oncogenic traits such as replication stress. RNA metabolic labeling and assessment of RNA velocity in patient-derived organoids revealed developmental trajectories of colorectal cancer cells organized along a mitogen-activated protein kinase activity gradient. This was in contrast to normal colon organoid cells developing along graded Wnt activity. Experimental targeting of EGFR-BRAF-MEK in cancer organoids affected signaling and gene expression contingent on predictive KRAS/BRAF mutations and induced cell plasticity overriding default developmental trajectories. Our results highlight directional cancer cell development as a driver of non-genetic cancer cell heterogeneity and re-routing of trajectories as a response to targeted therapy.
Asunto(s)
Palabras clave

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Neoplasias Colorrectales Idioma: En Revista: EMBO Mol Med Asunto de la revista: BIOLOGIA MOLECULAR Año: 2021 Tipo del documento: Article

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Neoplasias Colorrectales Idioma: En Revista: EMBO Mol Med Asunto de la revista: BIOLOGIA MOLECULAR Año: 2021 Tipo del documento: Article